Research-only notice: This article is for informational and research purposes only. Consult a qualified healthcare professional before using any peptide compounds. PepSync helps with logging and calculations; it does not provide medical advice, dosing recommendations, treatment plans, or safety guarantees.

For most research peptides, administration is by injection — either subcutaneous (under the skin) or intramuscular (into muscle tissue). The choice between these routes affects absorption rate, bioavailability, local tissue response, and practical ease of self-administration. Understanding the difference helps you match the administration method to the specific peptide and research research notes.

Subcutaneous (Sub-Q) Injection

Subcutaneous injection places the compound into the fatty tissue layer between skin and muscle. This is the most common administration route for research peptides and the easiest to self-record correctly.

How Subcutaneous Absorption Works

Sub-Q tissue has a rich capillary network that absorbs injected compounds over 15–30 minutes, providing a relatively slow and sustained release into circulation compared to intravenous injection. For most peptides, this gradual absorption is appropriate and preferable.

Subcutaneous Injection Sites

  • Abdomen: The preferred site for most research peptides. Target the fatty tissue 2–4 inches from the navel, avoiding the navel itself. Pinch a fold of skin and inject at 45° angle with a short needle.
  • Outer thigh: Lateral (outer) aspect of the thigh midway between hip and knee. Easy to access and good fat distribution in most individuals.
  • Upper arm: Posterior aspect (back of the upper arm). Requires some flexibility to self-record accurately; easier with assistance.
  • Lower back/flank: Some researchers use this area, though it's less conventional for self-administration.

Needle Selection for Sub-Q

  • Gauge: 27–31 gauge. Higher gauge = finer needle = less discomfort. 29 or 30 gauge is most common for research peptide sub-Q administration.
  • Length: 1/2 inch (12.7mm) or 5/16 inch (8mm). Short needles are appropriate — sub-Q injections only need to penetrate to the fat layer, not to muscle depth.
  • Insulin syringes: U-100 insulin syringes typically come with attached 28–31 gauge, 1/2 inch needles, making them ideal for sub-Q peptide administration.

Sub-Q Injection Technique

  1. Clean injection site with alcohol wipe. Allow to dry — injecting through wet alcohol causes a brief sting.
  2. Pinch a fold of skin between thumb and forefinger (lifts fat away from muscle).
  3. Insert needle at approximately 45° angle into the pinched fold. Some researchers prefer 90° for insulin syringe needles in areas with adequate fat.
  4. Do not aspirate (pulling back to check for blood) — this is no longer recommended practice for sub-Q injections and is unnecessary with the fine gauge needles used for peptides.
  5. Inject the solution slowly and steadily.
  6. Withdraw needle. Apply gentle pressure with a clean cotton swab or gauze if needed.
  7. Rotate injection sites between sessions.

Intramuscular (IM) Injection

Intramuscular injection places the compound into muscle tissue, which provides a faster absorption rate than subcutaneous tissue due to higher blood flow in muscle. IM injections are more commonly used for compounds where rapid onset is desired or where sub-Q administration causes local reactions.

Common IM Sites for Research Peptides

  • Deltoid (shoulder): The most accessible IM site for self-administration. Target the muscle bulk in the upper, outer area of the shoulder. Volume limit: 1mL for a single injection.
  • Vastus lateralis (outer thigh): The outer portion of the quadriceps. Good for larger volumes (up to 2mL). Easy to self-record.
  • Gluteus (buttock): Largest IM site. Requires assistance or awkward positioning for self-administration. Can accommodate larger volumes (3mL) but not commonly used for peptide research.

Needle Selection for IM

  • Gauge: 23–25 gauge for most IM injections. Thicker than sub-Q needles due to deeper penetration requirement and often larger volumes.
  • Length: 1 inch (25mm) for most individuals in deltoid; 1–1.5 inch for vastus lateralis depending on body composition.

IM Injection Technique

  1. Clean site with alcohol wipe. Allow to dry.
  2. Do not pinch skin — stretch it flat (Z-track technique optional for larger volumes to prevent backflow).
  3. Insert needle at 90° angle with a single, confident motion.
  4. Aspirate optional (the recommendation to aspirate for IM injections varies by current guidelines; most clinical guidelines have moved away from aspiration for standard IM sites).
  5. Inject solution steadily over 3–5 seconds for larger volumes.
  6. Withdraw at same angle as insertion.
  7. Apply gentle pressure; massage gently to distribute solution.

Which Route for Which Peptides?

Typically Sub-Q

  • BPC-157: Sub-Q is most common; absorbed well from sub-Q fat
  • Ipamorelin, GHRP-6, CJC-1295: Sub-Q standard
  • Semaglutide: Sub-Q standard (as used in pharmaceutical preparations)
  • IGF-1 LR3: Sub-Q near target tissue in some research notes

Sub-Q or IM

  • TB-500: Both routes are used. Sub-Q is more convenient; IM may theoretically provide faster systemic distribution for the larger molecule
  • Growth hormone: Both are used clinically; typically sub-Q for convenience

Sterile Technique: Non-Negotiables

  • Always wipe vial stoppers with alcohol before each puncture
  • Never reuse needles: Needles dull on first use; reuse creates increased pain and infection risk
  • Rotate injection sites: Using the same site repeatedly causes localized lipodystrophy (fat tissue changes) and reduces absorption reliability
  • Dispose of needles safely: Sharps containers are required for proper disposal in most jurisdictions
  • Work with clean hands — wash before handling syringes and vials
  • Inspect solution before drawing: Never inject turbid, discolored, or particulate-containing solution